SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Five GEL SCN1A controls carried SCN1A missense variants that have previously been reported in association with epilepsy syndromes, including Dravet syndrome,31–35 or sudden unexpected death36,37 (Supplementary Table 4).